» Articles » PMID: 36831225

The Role and Mechanism of Transglutaminase 2 in Regulating Hippocampal Neurogenesis After Traumatic Brain Injury

Overview
Journal Cells
Publisher MDPI
Date 2023 Feb 25
PMID 36831225
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury usually results in neuronal loss and cognitive deficits. Promoting endogenous neurogenesis has been considered as a viable treatment option to improve functional recovery after TBI. However, neural stem/progenitor cells (NSPCs) in neurogenic regions are often unable to migrate and differentiate into mature neurons at the injury site. Transglutaminase 2 (TGM2) has been identified as a crucial component of neurogenic niche, and significantly dysregulated after TBI. Therefore, we speculate that TGM2 may play an important role in neurogenesis after TBI, and strategies targeting TGM2 to promote endogenous neural regeneration may be applied in TBI therapy. Using a tamoxifen-induced conditional knockout mouse line and a mouse model of stab wound injury, we investigated the role and mechanism of TGM2 in regulating hippocampal neurogenesis after TBI. We found that was highly expressed in adult NSPCs and up-regulated after TBI. Conditional deletion of resulted in the impaired proliferation and differentiation of NSPCs, while overexpression enhanced the abilities of self-renewal, proliferation, differentiation, and migration of NSPCs after TBI. Importantly, injection of lentivirus overexpressing TGM2 significantly promoted hippocampal neurogenesis after TBI. Therefore, TGM2 is a key regulator of hippocampal neurogenesis and a pivotal therapeutic target for intervention following TBI.

Citing Articles

Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors.

Buccarelli M, Castellani G, Fiorentino V, Pizzimenti C, Beninati S, Ricci-Vitiani L Cells. 2024; 13(8.

PMID: 38667282 PMC: 11048792. DOI: 10.3390/cells13080667.


Tpr Misregulation in Hippocampal Neural Stem Cells in Mouse Models of Alzheimer's Disease.

Malik S, Lin J, Ziegler-Waldkirch S, Tholen S, Deshpande S, Schwabenland M Cells. 2023; 12(23).

PMID: 38067185 PMC: 10706632. DOI: 10.3390/cells12232757.


Agomir-331 Suppresses Reactive Gliosis and Neuroinflammation after Traumatic Brain Injury.

Wang J, Xiao X, He X, He B, Liu C, Teng Z Cells. 2023; 12(20).

PMID: 37887272 PMC: 10605079. DOI: 10.3390/cells12202429.


Targeting circulating tumor cells to prevent metastases.

Gostomczyk K, Marsool M, Tayyab H, Pandey A, Borowczak J, Macome F Hum Cell. 2023; 37(1):101-120.

PMID: 37874534 PMC: 10764589. DOI: 10.1007/s13577-023-00992-6.

References
1.
Brett B, Gardner R, Godbout J, Dams-OConnor K, Keene C . Traumatic Brain Injury and Risk of Neurodegenerative Disorder. Biol Psychiatry. 2021; 91(5):498-507. PMC: 8636548. DOI: 10.1016/j.biopsych.2021.05.025. View

2.
Kjell J, Fischer-Sternjak J, Thompson A, Friess C, Sticco M, Salinas F . Defining the Adult Neural Stem Cell Niche Proteome Identifies Key Regulators of Adult Neurogenesis. Cell Stem Cell. 2020; 26(2):277-293.e8. PMC: 7005820. DOI: 10.1016/j.stem.2020.01.002. View

3.
Faiz M, Sachewsky N, Gascon S, Bang K, Morshead C, Nagy A . Adult Neural Stem Cells from the Subventricular Zone Give Rise to Reactive Astrocytes in the Cortex after Stroke. Cell Stem Cell. 2015; 17(5):624-34. DOI: 10.1016/j.stem.2015.08.002. View

4.
Taylor C, Jhaveri D, Bartlett P . The therapeutic potential of endogenous hippocampal stem cells for the treatment of neurological disorders. Front Cell Neurosci. 2013; 7:5. PMC: 3556583. DOI: 10.3389/fncel.2013.00005. View

5.
Hummerich R, Thumfart J, Findeisen P, Bartsch D, Schloss P . Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation. FEBS Lett. 2012; 586(19):3421-8. DOI: 10.1016/j.febslet.2012.07.062. View